Royce & Associates’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.71M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $2.46M | Sell |
|
|||||
|
2023
Q2 | $3.32M | Sell |
|
|||||
|
2023
Q1 | $3.45M | Buy |
|
|||||
|
2022
Q4 | $1.85M | Buy |
|
|||||
|
2022
Q3 | $774K | Buy |
|
|||||
|
2022
Q2 | $408K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $2.21M | Hold |
|
|||||
|
2020
Q1 | $1.94M | Hold |
|
|||||
|
2019
Q4 | $2.46M | Hold |
|
|||||
|
2019
Q3 | $2.14M | Hold |
|
|||||
|
2019
Q2 | $3.08M | Buy |
|
|||||
|
2019
Q1 | $1.63M | Buy |
|
|||||
|
2018
Q4 | $1.19M | Buy |
|
|||||
|
2018
Q3 | $2.13M | Sell |
|
|||||
|
2018
Q2 | $2.88M | Sell |
|
|||||
|
2018
Q1 | $2.3M | Buy |
|
|||||
|
2017
Q4 | $1.96M | Buy |
|